Final Overall Survival Analysis of S1500: A Randomized, Phase II Study Comparing Sunitinib With Cabozantinib, Crizotinib, and Savolitinib in Advanced Papillary Renal Cell Carcinoma
National Cancer Institute (NCI)
Pedro Barata; Catherine Tangen; Melissa Plets; Ian M Thompson; Vivek Narayan; Daniel J George; Daniel Y C Heng; Brian Shuch; Mark Stein; Shuchi Gulati; Maria Tretiakova; Abhishek Tripathi; Georg A Bjarnason; Peter Humphrey; Adebowale Adeniran; Ulka Vaishampayan; Ajjai Alva; Tian Zhang; Scott Cole; Primo N Lara; Seth P Lerner; Naomi Balzer-Haas; Sumanta K Pal
SWOG Statistics and Data Management Center, Seattle, WA. ; SWOG Statistics and Data Management Center, Seattle, WA.